Clinical Trial Update: Ph1 Study of Valortim and Ciprofloxacin in Humans [Phase 1]

View source ↗

Summary

A Phase 1 study of Valortim in combination with Ciprofloxacin for anthrax has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Valortim (MDX-1303)

Snippet

Sponsor: PharmAthene, Inc. | Conditions: Anthrax | Phase 1 | Status: SUSPENDED